
B-Cell Inhibitors Market Poised For Significant Advances During The Forecast Period (2025-2034) Across 7MM Due To Novel ...
(MENAFN- PR Newswire) The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which includes indications like IgAN, Multiple Sclerosis, Immune Thrombocytopenia, SLE, IgG4-RD, wAIHA, …